|
Safety of Therapeutic Apheresis in Children and Adolescents |
08/10/2022 - 3:30pm to 4:30pm EDT |
|
A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus Host Disease |
08/31/2022 - 3:30pm to 4:30pm EDT |
|
Safety and Tolerability of Solvent/Detergent-Treated Plasma for Pediatric Patients Requiring Therapeutic Plasma Exchange |
10/19/2022 - 3:30pm to 4:30pm EDT |
|
Comprehensive guide to managing a chronic automated red cell exchange program in sickle cell disease |
11/09/2022 - 3:30pm to 4:30pm EST |
|
Drug dosing in patients undergoing therapeutic plasma exchange |
01/25/2023 - 3:30pm to 4:30pm EST |
|
Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplant |
02/22/2023 - 3:30pm to 4:30pm EST |
|
The ADAPT trial for myasthenia gravis |
05/31/2023 - 3:30pm to 4:03pm EDT |
|
Efficacy and cost of double filtration plasmapheresis in severe hypertriglyceridemia-induced pancreatitis: A retrospective observational study |
08/09/2023 - 3:30pm to 4:30pm EDT |
|
Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturer |
08/16/2023 - 3:30pm to 4:30pm EDT |
|
Ethylene oxide-type hypersensitivity reactions in G-CSF mobilized, peripheral blood hematopoietic progenitor cell donors |
09/27/2023 - 3:30pm to 4:30pm EDT |
Facebook
X
LinkedIn
Forward